Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • September 22, 2024

Tangri N, Rastogi A, Sofue T. Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Sep 19. doi: 10.1007/s12325-024-02961-3. Epub ahead of print. PMID: 39298075.

Tags: albuminuria, Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT-2i, Urinary albumin-to-creatinine ratio

Acute Renal Failure Due to Amyloidosis Associated With Intravenous Heroin Use

Malchira R, Shye M, Konanur R, Sidhu H, Zuckerman J. Acute Renal Failure Due to Amyloidosis Associated With Intravenous Heroin Use. Cureus. 2025 Jul 27;17(7):e88860.[...]

The Association of Niacin Use with Kidney Outcomes and Mortality

Takahashi R, Bui TA, Elali I, Tran D, Sumida K, Thomas F, Dukkipati R, Shah A, Rhee CM, Kovesdy CP, Kalantar-Zadeh K, Takahashi R. The[...]

Inter-organ crosstalk: The kidney’s role in systemic health and disease

Zoccali C, Agarwal R, Mallamaci F, Jager KJ, Stel V, Kanbay M, Pollock C, Kalantar-Zadeh K, Ronco C, Vanholder R. Inter-organ crosstalk: The kidney's role[...]